Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CPT-157633 is a difluoro-phosphonomethyl phenylalanine derivative that acts as a potent inhibitor of the enzyme PTP1B. It effectively prevents the development of glucose intolerance induced by binge drinking.
Description | CPT-157633 is a difluoro-phosphonomethyl phenylalanine derivative that acts as a potent inhibitor of the enzyme PTP1B. It effectively prevents the development of glucose intolerance induced by binge drinking. |
In vivo | CPT-157633, administered via intracerebroventricular infusion at a dose of 0.2 μg/day, mitigates hypothalamic inflammation and glucose intolerance resulting from binge drinking in rats[1]. |
Molecular Weight | 465.2 |
Formula | C12H16BrF2N2O6PS |
CAS No. | 888213-72-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CPT-157633 888213-72-7 CPT157633 CPT 157633 inhibitor inhibit